by John A. Jenkins | Apr 11, 2024 | FDA, FOIA, Medical Devices
FOIAengine: As Deaths Mounted, J&J “Promised to Correct” – and Sought FDA Records Johnson & Johnson (NYSE: JNJ) proudly calls itself “the world’s largest and most diversified healthcare products company.” The company had $85 billion in sales last year, and...
by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices
FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...